|
|
|
|
|
|
|
|
|
12.08.26 - 22:09
|
Omeros Corporation Reports Second Quarter 2026 Financial Results (Business Wire)
|
|
|
– Conference Call Today at 4:30 p.m. ETSEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2026, which include:
Second Quarter and Recent Highlights
YARTEMLEA®, the first and only approved treatment for stem cell transplant-associated thrombotic microangiopathy (TA-TMA), an often-lethal complication of stem cell transplantation, generated gross revenues of $32.2 million in the second quarter of 2026, an increase of 190% from $11.1 million in the first quarter. Net revenue was $28.5 million, reflecting gross-to-net adjustments of approximately 11.5%, compared with $9.9 million and 11.0%, respectively, in the first quarter.
Net income for the second quarter of 2026 was $13.2 million, or $0.18 per share, compared to net income of $56.1 million, or $0.78 per share for the first quarter of 2026.
Results for the second and first quarters of 2026 included non-cash gains of $11.5 millio...
|
|
|
|
|
10.08.26 - 14:03
|
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026 (Business Wire)
|
|
|
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the second quarter of 2026 on Wednesday, August 12, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company's financial results.
Conference Call Details and Webcast Link Instructions
To access the live webcast, please click here or visit the “Upcoming Events” section of the Investor Relations page of Omeros' website.
A replay of the call will be available for 90 days in the “Archived Events” section of the Investor Relations page of Omeros' website.
As Omeros continues to transition to a new earnings call platform (hosted by Q4 Inc.), please allow extra time to log in prior to the start of the call.
About Omeros Corporation
Omeros is an innovative biotechnology company that discovers and develops first-in-class protei...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.06.26 - 14:36
|
Omeros Announces Webcast Details for Annual Meeting of Shareholders (Business Wire)
|
|
|
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Thursday, June 18, 2026, beginning at 10:00 a.m. Pacific Time.
The live webcast can be accessed through the virtual shareholder meeting website at www.virtualshareholdermeeting.com/OMER2026. A general corporate overview and question-and-answer session will follow the business portion of the annual meeting.
As described in the company's proxy statement, filed April 30, 2026, only shareholders of record as of the close of business on April 17, 2026 are entitled to vote at the Annual Meeting of Shareholders and any adjournment or postponement thereof. Shareholders of record will be able to attend the meeting, vote and submit questions through the virtual shareholder meeting website by using the 16-digit control number provided on their proxy card or in the instructions accompanying their proxy materials.
Guests without a ...
|
|
|
04.06.26 - 17:30
|
Bears are Losing Control Over Omeros (OMER), Here′s Why It′s a ′Buy′ Now (Zacks)
|
|
|
Omeros (OMER) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
